Patents matching “The United States of America”

US 7105643

Monoclonal antibodies specific for crack cocaine metabolites, a cell line producing the same, and crack cocaine conjugates

The United States of America as represented by the Attorney General of the Dept. of Justice · Granted Sep 12, 2006 · Expires Sep 7, 2026

US 7105170

Latent human tuberculosis model, diagnostic antigens, and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 12, 2006 · Expires Sep 7, 2026

US 7105169

Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 12, 2006 · Expires Sep 7, 2026

US 7105488

G protein-coupled receptor antagonists

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 12, 2006 · Expires Sep 7, 2026

US 7101548

Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 5, 2006 · Expires Aug 31, 2026

US 7101547

Method for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance P by using anti-substance P antibodies

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 5, 2006 · Expires Aug 31, 2026

US 7101541

Utilization of non-viral sequences for minus-strand DNA transfer and gene reconstitution

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 5, 2006 · Expires Aug 31, 2026

US 7097965

Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 29, 2006 · Expires Aug 24, 2026

US 7094405

Peptides which elicit a high neutralizing antibody titer, cytotoxic T lymphocyte response and T helper cell response in a broad range of MHC type recipients

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 22, 2006 · Expires Aug 17, 2026

US 7094883

Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein

The United States of America as represented by the Secretary of the Army · Granted Aug 22, 2006 · Expires Aug 17, 2026

US 7094406

Enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes thereof

The United States of America as represented by the Secretary of the Department of Health and Human Services and Genelabs Technologies, Inc. · Granted Aug 22, 2006 · Expires Aug 17, 2026

US 7094411

Avirulent, immunogenic flavivirus chimeras

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 22, 2006 · Expires Aug 17, 2026

US 7094408

Immunogenicity using a combination of DNA and vaccinia virus vector vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 22, 2006 · Expires Aug 17, 2026

US 7094404

Method for treating malignancy and autoimmune disorders in humans using tac antibodies

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 22, 2006 · Expires Aug 17, 2026

US 7094598

Development of a preventive vaccine for filovirus infection in primates

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 22, 2006 · Expires Aug 17, 2026

US 7094045

Microencapsulation system and method

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Aug 22, 2006 · Expires Aug 17, 2026

US 7090852

Venezuelan equine encephalitis virus replicon encoding marburg virus proteins

The United States of America as represented by the Secretary of the Army · Granted Aug 15, 2006 · Expires Aug 10, 2026

US 7087591

21-substituted progesterone derivatives as new antiprogestational agents

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 8, 2006 · Expires Aug 3, 2026

US 7087589

Methanocarba cycloakyl nucleoside analogues

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 8, 2006 · Expires Aug 3, 2026

US 7087234

Recombinant multivalent viral vaccine

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 8, 2006 · Expires Aug 3, 2026

US 7084132

Artemisinins with improved stability and bioavailability for therapeutic drug development and application

The United States of America as represented by the Secretary of the Army · Granted Aug 1, 2006 · Expires Jul 27, 2026

US 7084266

Cloned genome of infectious hepatitus C virus of genotype 2A and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 1, 2006 · Expires Jul 27, 2026

US 7084239

Cancer peptides of NY-ESO-1/CAG-3

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 1, 2006 · Expires Jul 27, 2026

US 7081524

O2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates

The United States of America, as represented by the Department of Health and Human Services · Granted Jul 25, 2006 · Expires Jul 20, 2026